We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Streptococcus pneumoniae in the USA: in vitro susceptibility and pharmacodynamic analysis.
- Authors
Mason, Edward O.; Lamberth, Linda B.; Kershaw, Nerisa L.; Prosser, Barbara La T.; Zoe, Annette; Ambrose, Paul G.; Mason, E O Jr; Lamberth, L B; Kershaw, N L; Prosser, B L; Zoe, A; Ambrose, P G
- Abstract
Ninety-two laboratories in the USA submitted isolates of Streptococcus pneumoniae to a single laboratory for susceptibility testing. Overall, 64% of 4489 isolates were susceptible to penicillin, 24% were intermediate and 13% were resistant to penicillin, although susceptibilities varied depending on geographical region. Macrolide/azalide resistance varied from 4 to 30%, with some regions having macrolide/azalide resistance higher than penicillin resistance. Children 12 years of age were significantly more likely to be infected with a penicillin-resistant pneumococcus than were adolescents or adults. Isolates from the respiratory tract were more likely to be penicillin resistant and >50% of pneumococci from the ear were resistant to penicillin. Almost 25% of penicillin-susceptible isolates had cefaclor MICs 2.0 mg/L and 15% of penicillin-susceptible isolates had loracarbef MICs 2.0 mg/L. These isolates would be erroneously reported as susceptible using NCCLS guidelines, and this finding may explain the lack of clinical response in patients treated with these antibiotics. The predicted plasma concentrations of all cephalosporins tested exceeded the geometric mean MIC for at least 40% of the dosing interval for penicillin-susceptible S. pneumoniae; for penicillin-intermediate S. pneumoniae, only cefprozil (56%), cefuroxime (64%) and cefpodoxime (63%) reached >40% of time above the geometric mean MIC in the dosing interval. None of the cephalosporins evaluated achieved a substantial time above the geometric mean MIC during its dosing interval for fully penicillin-resistant S. pneumoniae.
- Subjects
UNITED States; ANTIBIOTICS; COMPARATIVE studies; DRUG resistance in microorganisms; RESEARCH methodology; MEDICAL cooperation; MICROBIAL sensitivity tests; RESEARCH; STREPTOCOCCAL diseases; STREPTOCOCCUS; EVALUATION research; PHARMACODYNAMICS
- Publication
Journal of Antimicrobial Chemotherapy (JAC), 2000, Vol 45, Issue 5, p623
- ISSN
0305-7453
- Publication type
journal article
- DOI
10.1093/jac/45.5.623